Stephen Carey
Directeur Financier/CFO chez ANI PHARMACEUTICALS, INC.
Fortune : 11 M $ au 30/04/2024
Profil
Stephen P.
Carey is currently the Chief Financial Officer & Senior VP-Finance at ANI Pharmaceuticals, Inc. Prior to his current position, he worked as the Chief Accounting Officer, Senior VP & Controller at Endo Generics Holdings, Inc. from 2007 to 2015.
Mr. Carey obtained his undergraduate degree from Montclair State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/04/2024 | 166 968 ( 0,80% ) | 11 M $ | 30/04/2024 |
Postes actifs de Stephen Carey
| Sociétés | Poste | Début |
|---|---|---|
| ANI PHARMACEUTICALS, INC. | Directeur Financier/CFO | 06/05/2016 |
Anciens postes connus de Stephen Carey
| Sociétés | Poste | Fin |
|---|---|---|
| PAR PHARMACEUTICAL COMPANIES, INC. | Comptroller/Controller/Auditor | 01/10/2015 |
Formation de Stephen Carey
| Montclair State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ANI PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Endo Generics Holdings, Inc.
 Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Endo Generics Holdings, Inc. develops, manufactures, and markets generic pharmaceutical products. It also offers dosage, branded, and generic sterile injectable products. The company was founded in 1978 and is headquartered in New York, NY. | Health Technology |